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Abstract
Background: Adults aged 65 and older with severe mental illnesses are a growing segment of the Dutch
population. Some of them have a range of serious problems and are also difficult to engage. While assertive
community treatment is a common model for treating difficult to engage severe mental illnesses patients, no
special form of it is available for the elderly. A special assertive community treatment team for the elderly is
developed in Rotterdam, the Netherlands and tested for its effectiveness.
Methods: We will use a randomized controlled trial design to compare the effects of assertive community
treatment for the elderly with those of care as usual. Primary outcome measures will be the number of dropouts,
the number of patients engaged in care and patient’s psychiatric symptoms, somatic symptoms, and social
functioning. Secondary outcome measures are the number of unmet needs, the subjective quality of life and
patients’ satisfaction. Other secondary outcomes include the number of crisis contacts, rates of voluntary and
involuntary admission, and length of stay. Inclusion criteria are aged 65 plus, the presence of a mental disorder, a
lack of motivation for treatment and at least four suspected problems with functioning (addiction, somatic
problems, daily living activities, housing etc.). If patients meet the inclusion criteria, they will be randomly allocated
to either assertive community treatment for the elderly or care as usual. Trained assessors will use mainly
observational instruments at the following time points: at baseline, after 9 and 18 months.
Discussion: This study will help establish whether assertive community treatment for the elderly produces better
results than care as usual in elderly people with severe mental illnesses who are difficult to engage. When assertive
community treatment for the elderly proves valuable in these respects, it can be tested and implemented more
widely, and mechanisms for its effects investigated.
Trial Registration: The Netherlands National Trial Register NTR1620
Background
Adults aged 65 plus are a fast-growing segment of the
Dutch population. This sharp rise is leading to an increase
in the number of elderly people who live on their own and
who have psychiatric disorders [1,2]. Just 8%-16% of
elderly people with such disorders receive treatment from
a healthcare provider [1,3,4]. This group of older psychia-
tric patients is not only difficult to engage, but often also
has a range of serious problems in other aspects of their
lives [2]. Some of them neglect themselves and their
immediate surroundings, and thus live in extreme squalor
[5,6]. Exact numbers of (self)-neglected elderly are not
known [5,6]. But elderly in the community with depressive
symptoms or cognitive impairment are at risk for develop-
ment of self-neglect [7] and more than half of the elderly
who are neglecting their environment has a psychiatric
disorder such as dementia, paranoid disorder, addiction or
depression [6]. It is unknown whether mental healthcare
services to date are sufficient to help them, e.g. because
these patients drop out of care due to the lack of motiva-
tion, [8,9], or whether active outreach care, such as asser-
tive community treatment (ACT), is needed.
In adult mental healthcare, ACT is a much-examined,
frequently used organizational model for treating diffi-
cult-to-engage patients with severe mental illness (SMI;
10, 11). Particularly in the United States, ACT has been
proven to be effective in reducing admissions and making
patients’ housing status more stable. It improves patients’
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satisfaction and motivation for treatment [12,13]. A rela-
tively high number of ACT patients also remain in care
[14,15]. We think this last observation is very important,
since drop out of care may lead to further deterioration.
European studies, however, have been less unanimous
about the effects of ACT and showed no difference
between ACT and care as usual (CAU) in terms of psy-
chosocial functioning and hospital admission days
[16-18]. Part of this discrepancy may be explained by
improvements in the quality of CAU in Western Europe
[19,20], but also by the fact that CAU contains some
features of ACT [21].
Intervention studies for SMI elderly in the community
are rare. Two studies showed that intensive community
care given to depressive elderly people (sometimes with
delusions) caused a fall in the number of admissions to
a psychiatric unit, stabilization of psychiatric symptoms,
and an improvement in quality of life [22,23] as com-
pared to CAU. Another study showed that psychiatric
symptoms and functioning improved when elderly peo-
ple with psychiatric problems received outreach services
rather than office-based ones [3]. We found no studies
that focused on the effects of ACT for patients aged 65
and over.
Research aim
Using a randomized controlled trial (RCT) design, we
will compare the effects of ACT elderly (ACTE) with
those of CAU for elderly patients with SMI who are dif-
ficult to engage in care.
Hypotheses
Our first hypothesis is that ACTE will decrease the
number of patients who drop out of care (number of
patients who have no registered contact with the ser-
vices over a period of 3 months and/or the number of
patients discharged out of care). The other primary
hypotheses include that ACTE will increase the number
of patients engaged in care (patients who receive care
within 3 months after admission to the team) and will
improve patients’ psychiatric, somatic and social symp-
toms. Secondary hypotheses include that ACTE reduce
the number of unmet needs more than CAU does. We
also expect an increase in patients’ subjective quality of
life and in patients’ satisfaction with mental-health care.
Finally we hypothesize that to a greater extent than
CAU, ACTE will reduce the number of crisis contacts,
reduce voluntary and involuntary admission rates and
reduce length of stay in a psychiatric hospital.
Methods - Design
This trial is being funded by BavoEuropoort centre for
mental healthcare, Rotterdam, the Netherlands.
Research design
This RCT will use one intervention group consisting of
patients who receive treatment according to ACTE, and
one control group consisting of patients who receive treat-
ment according to CAU. We will use a pre-randomized
block design, with four patients per block, whereby
patients are randomized before they consent to participate,
the so-called Zelen’s design [24]. The design and execution
of this study were approved by the Dutch union of medi-
cal-ethic trial committees for mental health organizations
Participants - setting
The study was carried out in the Netherlands by
BavoEuropoort centre for mental healthcare in the
greater Rotterdam area (1.3 million residents). BavoEur-
opoort has 1,300 staff, who are employed at 32 sites in
eleven municipalities. It provides treatment and gui-
dance to people in whom complex psychiatric disorders
are combined with problems in several life domains. It
has various outpatient clinics and clinical settings for
voluntary or involuntary admission. There are six ACT
teams for patients who are difficult to engage in treat-
ment. One of these teams focuses on elderly patients.
BavoEuropoort also provides mental healthcare services
for elderly people (55+) in their third and fourth stages
of life who have mental health complaints and/or cogni-
tive disorders.
Participants are elderly outpatients (aged 65 years or
older) with severe psychiatric problems, who are difficult
to engage, and who are resident in the BavoEuropoort
catchment areas.
Procedure
BavoEuropoort has one ACT team for elderly people
(intervention condition). In the control condition
(CAU), participants were identified by three general
community mental health teams working for elderly
people living in the community. Two of these teams
focused on patients with psychiatric disorders; the
other focused mainly on patients with cognitive impair-
ments. Community mental healthcare professionals
from these teams will use a checklist to determine
whether all new elderly service-users meet the inclu-
sion criteria. The inclusion of patients started July 2008
and was closed on 1 August 2010.
Figure 1 shows the inclusion flowchart; inclusion
criteria are:
1. age 65 year or older;
2. having a severe mental illness (patients with a
severe psychiatric disorder, usually psychotic or bipo-
lar disorder or severe depression, leading to a com-
plex combination of psychiatric and social needs).
Stobbe et al. BMC Psychiatry 2010, 10:84
http://www.biomedcentral.com/1471-244X/10/84
Page 2 of 9
3. no motivation for treatment (actively or passively
resisting treatment; the patient is very difficult to
involve in any form of treatment, including treat-
ment by the general practitioner).
4. and 4 problems of the following domains:
- addiction: taking alcohol and drugs taking not in a
social context, occasional minimal loss of control of
drinking or drugs use or adverse consequences or
incapacitated due to alcohol or drug problems.
- somatic problems: all kind of somatic problems,
including illness or disability from any cause that lim-
its mobility, impairs sight or hearing, or otherwise
interferes with personal functioning.
- daily living activities: the overall level of function-
ing in activities of daily living: e.g., problems with
basic activities of self-care such as eating, washing,
dressing, toilet; also complex skills such as budget-
ing, recreation and use of transport, etc.
- housing: the overall severity of problems regarding
the quality of living conditions, accommodation and
daily domestic routine, taking into account of the
patient’s preferences and degree of satisfaction with
such circumstances. Are the basic necessities met?
- daytime activities: the overall level of problems
regarding the quality of the daytime environment.
Limited or no daytime activities. The patients pro-
blems are made worse by a lack of daytime activities.
- social relationships: problems associated with social
relationships, as identified by the patient or apparent
to carers or others. These included active or passive
withdrawal from social relationships, a tendency to
dominate, social relationships or non-supportive,
destructive or self-damaging relationships.
- finances: problems associated with finance (such as
debts), and problems with skills such as budgeting.
- police contacts: contact within police in the last
year that were a product of the patients psychologi-
cal situation. Examples: nuisance, public drunken-
ness or minor offence by psychological situation.
We exclude patients with severe cognitive problems
(severely disorientated, for example consistently disorien-
tated with regards to time to time, place, or person, or suf-
fering memory impairment for example only fragments
remain, loss of distant as well as recent information,
unable to effectively learn any new information, no effec-
tive communication possible through language or inacces-
sible to speech.
Primary and secondary outcome variables were collected
by means of an interview of patients willing to give
informed consent as well as from the patients’ files. A
trained independent research assessor will record these
primary and secondary outcome measures. This research
assessor contacts after patient randomization the clinician
Figure 1 Inclusion flowchart.
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to make an appointment to visit the patient together. In
this contact with the patient the research assessor asked
questions (via semi structured interview) to rate the
assessment instruments. Because patients are difficult to
engage they don’t fill in questionnaires themselves. If
patients refuse to answer questions, the research assessor
will collect data from the patient’s records or via asking
the clinician about the patients’ situation. Data are col-
lected as part of the routine outcome assessments of the
mental health centre. The first interview was done closely
after inclusion in the study. The second interview took
place 9 months after the first and the last interview after
18 months.
Intervention and care as usual
The intervention will be ACTE, an integrated multidisci-
plinary treatment model. It will have four main compo-
nents: 1.) the caseload will be both small and shared
(10 patients per case manager), 2.) services and assertive
outreach will all be community based, 3.) all services
(i.e. both medical and psychosocial) will be provided by
the ACTE team, and 4.) and all services will be provided
on an unlimited basis [25-27].
ACTE has been described in a manual that describes
the target group, the team’s working method, and tasks
of the various disciplines involved. It also includes var-
ious programmes (modules) based on other evidence-
based practices. Under ACTE, care is given with regard
to various essential life domains, at whichever location
the patient is [28]. Professional mental healthcare work-
ers invest in a long time relationship with the patient,
even if he or she initially continues to refuse care.
To address the most common problems of the target
group, the ACTE team will represent several disciplines
(table 1), and will have ten full-time equivalents working
force. The low caseload will allow for intensive contact
with patients. Team members will collaborate closely on
each patient, using one treatment plan.
Table 1 contrasts ACTE working methods with those
of CAU [25,26] and [27]), the latter consisting of three
teams: a psycho-geriatric team for elderly patients with
cognitive problems and two gerontology psychiatric
team for elderly patients with psychiatric problems.
Table 1 shows that the main differences between ACTE
and CAU will concern team approach including a shared
caseload, contact frequency, and the location of care pro-
vision. Because care under ACTE will be provided in the
patient’s living environment, there will often be intensive
collaboration with a number of organizations (such as
the police in cases of nuisance or homelessness, or with
psychiatric hospitals upon admission). Because this group
of elderly psychiatric patients is difficult to engage in
treatment and may have bad experiences with the care-
provision circuit, it is very important than time and
energy are devoted to establishing contact with them.
Outcomes and measurement instruments
Our primary outcome measures will be the number of
dropouts (drop-out being defined as no registered con-
tact with the services over a period of 3 months and/or
the number of patients discharged out of care). The
number of patients who are engaged in care (patients
who receive care within 3 months after admission) and
patient’s psychiatric symptoms, somatic symptoms, and
social functioning.
Our secondary outcomes measures will be
1. The number of unmet needs,
2. Subjective quality of life,
3. Patients’ satisfaction with mental-health care,
4. The number of crisis contacts and (in)voluntary
admissions, and the number of admission days. The
admission days and crisis contacts were calculated
during two periods of observation. The first period
was the year before inclusion in the study. The sec-
ond was the variable observation period ranging till
2 years after inclusion. In both periods, the admis-
sion data were standardized as mean number of days
per month and crisis contacts as mean number.
Assessment instruments
Measurements will be made at three points of the study:
at baseline, and after 9 and 18 months. In the meantime,
the patients will be treated according to the ACT model
or CAU. The same instruments will be used for all three
measurements.
The following data will be obtained from the patient’s
electronic records:
- Demographic and socio-economic characteristics
(including gender, age, ethnicity),
- Data concerning living situation, homelessness,
employment, and education,
- The psychiatric diagnosis,
- Use of medication,
- Deaths (included suicide) and
- Data on the number of patients who are engaged
in care, the number of dropouts and the time
between the start of the treatment and dropout.
Also the number of crisis contacts and voluntary
and involuntary admissions, and the length of stay of
admission will be collected.
Using assessment instruments, the following data will
be collected:
- Psychosocial functioning (psychiatric, somatic and
social symptoms/functioning) by means of the health
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of nations outcome scale for the elderly (HoNOS
65+, Dutch version) [29,30]
- Care needs by means of the abridged Camberwell
assessment of needs elderly (CANE, short version,
Dutch version [31,32].
- Quality of life by means of the quality of life (QoL,
abridged version of the Manchester short assessment
of quality of life; [33,34].
HoNOS 65+
The purpose of the HoNOS 65+ [29,30] is to describe
the psychological and social functioning of elderly psy-
chiatric patients, and to provide insight into the severity
of various psychosocial problems by identifying changes
in relevant areas of life.
The HoNOS 65+ can be used to measure the effect of
treatment. It consists of 12 items in four sub-scales: beha-
vior disturbance (items 1-3), impairment (items 4-5),
symptoms (items 6-8), and social problems (items 9-12). A
Dutch addendum to the HoNOS 65+ contains three ques-
tions on problems resulting from manic-depressive disor-
der, motivation for treatment, and medication compliance.
These items have not been validated [35]. All items will be
completed on a 5-point Likert scale from 0 (no problem),
1 (minor problem), 2 (mild problem), 3 (moderate pro-
blem), to 4 (severe problem). The Dutch version of the
HoNOS 65+ has been shown to be properly valid [36].
Cane
The CANE [31,32] establishes whether an elderly person
has problems and/or care needs in various areas of life,
and, if necessary, whether adequate effective care is being
given. It consists of 26 questions on items such as needing
a diet, daily activities, and psychotic symptoms. Care
needs are scored in the following manner: 0 (no need), 1
(met need), and 2 (unmet need).
QoL
Quality of life will be measured using the QoL scale,
which has shown itself to be well suited to measuring
satisfaction in the chronic psychiatric target group
[33,34]. Dealing with patients’ subjective perceptions
with respect to quality of life, the scale consists of six ele-
ments covering patients’ satisfaction with their 1.) life as
a whole, 2.) living situation, 3.) personal relationships 4.)
physical health, 5.) mental health and 6.) financial situa-
tion. Per item, the researcher will ask the patient to
award a score on a 7-point Likert scale ranging from 1
(bad or not at all satisfied) to 7 (good and very satisfied).
Table 1 Differences between ACTE and CAU
Intervention Group (ACTE) Control Group (CAU) Gerontology psychiatry
teams
Control Group (CAU) Psycho geriatric team
A shared caseload (all care providers know all
the patients and work together in the
treatment).
Individual care providers responsible for patient
assessment and for coordination and treatment.
Individual care providers responsible for patient
assessment and for coordination and treatment.
A low caseload (a maximum of ten patients in
the team per individual care provider).
A high caseload for the individual
practitioner (> 20).
A high caseload for the individual
practitioner (> 20).
The care provider takes the initiative on
maintaining contacts, and visits patients mainly
in their own environment, wherever they are
(also when they are hospitalized), the intention
being to prevent dropout.
In general, whether contact takes place in the
office or at home, involvement ceases
(temporarily) after admission has taken place, or
if the patient refuses to maintain (long-term)
contact. (Normally, there is no contact when
the patient is hospitalized.). If patient refuses
contact or fails to show up, discharge usually
follows.
In general, whether contact takes place in the
office or at home, involvement ceases
(temporarily) after admission has taken place, or
if the patient refuses to maintain (long-term)
contact. (Normally, there is no contact when
the patient is hospitalized.). If patient refuses
contact or fails to show up, discharge usually
follows.
Unlimited investment in terms of time (high
contact frequency).
Limited contacts, frequency as low as possible. Limited contacts, frequency as low as possible.
All aid is offered though the ACT team
(psychiatric treatment, rehabilitation, assistance
with addiction, financial problems, and
somatic care).
Only psychiatric care is provided. Addiction,
financial problems and other problems are
treated by other services.
Only psycho geriatric care is provided.
Addiction, financial problems and other
problems are treated by other services.
Disciplines:
Doctor of Medicine or nursing-home doctor
(especially for somatic problems) or visiting
geriatrist Social worker Psychiatrist Psychologist
Community Mental Health Nurse Rehabilitation
worker Somatic nurse, Mental Health nurse
Homecare worker One of above discipline is
specialized in addiction (or double diagnosis)
Disciplines:
Doctor of Medicine or nursing home doctor
Psychiatrist Psychologist, Community Mental
Health Nurse
Disciplines:
Doctor of Medicine or nursing home doctor or
visiting geriatrist Psychologist, Community
Mental Health Nurse
Each morning there will be a team meeting on
all patients in which any necessary
appointments are made
Patients are discussed in patient meetings once
every six months. Difficult cases are discussed
during weekly team meetings.
Patients are discussed in patient meetings once
every six months. Difficult cases are discussed
during weekly team meetings.
Staff will receive training in ACT methodology No specific staff training. No specific staff training.
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Satisfaction with the care-provider
The QoL scale will be extended with one question on
patients’ satisfaction with their treatment. This will be
taken from the satisfaction questionnaire [34], and, like
all answers in the QoL, be rated as a single question on
a 7-point Likert scale.
Other measurement instruments
Collaboration between patient and care-provider
The level of collaboration between patient and care pro-
vider will be analyzed using the relationship scale from
the working relationship questionnaire for case manage-
ment [37], which consists of seven elements that are
filled in by the care provider who is most familiar with
the patient. The care provider responsible for the file is
the one who is most familiar with the patient. In the
CAU this is the patient’s clinician. In the ACTE this is
the clinician who gets to know the patient best after the
intake procedure, and who is also the contact person for
family and institutions.
Model fidelity of ACT
Research has shown that ACT has the best results when
it is implemented in full according to the original ACT
model [20,38-44]. As recommended in the literature,
model fidelity will be determined on the basis of both
conditions [20].
The fidelity of ACT and CAU will be measured twice
(in 2010 and in 2011) by two independent researchers
using the Dartmouth assertive community treatment
scale (DACTS). The DACTS consists of 28 items cover-
ing three dimensions (team structure, organizational
structure, and features of service delivery). All twenty-
eight items are rated on a 5-point scale range from 1
(no implementation or only a low degree of implemen-
tation) to 5 (complete implementation) [45-47].
Table 2 shows an overview of all outcome measures
and instruments.
Power analysis
The sample size was determined by means of a power
analysis. To detect a clinically significant impact (aver-
age effect size (Cohen’s d) ≥ 0. 6) on the primary out-
come variable (number of patients remain in care with
an alpha of 0. 05 and a power of 0.85), we needed at
least 50 patients per condition. In another ACT trial,
Sytema et al [48] found 20% lose for randomization
due to patients’ failure to meet the inclusion criteria,
and patients who refused to give informed consent for
the interview [48]. We therefore wanted to include 80
patients in the ACTE team and 80 patients in the
CAU condition. This will be enough to prove a clini-
cally significant effect.
Randomization
The patients were referred to BavoEuropoort by general
practitioners or other institutions (such as the police or
municipal health service), who filled out a form describ-
ing the patient’s characteristics and current problems.
To determine whether the patients fulfilled the inclusion
criteria, this form was reviewed using a checklist by the
researcher (JS) and clinicians. If the patient did meet the
criteria, he or she was allocated a number chronologi-
cally by the service administrator. Each number was
given to the researcher, who then decided on the condi-
tion (intervention or care as usual). This was done on
the basis of a previously arranged list of numbers rando-
mized to each of the two conditions (with help from
http://www.randomizer.org). To ensure similar numbers
in both conditions the pre-arranged list of numbers are
based on a block design (block size of four). Inclusion
and randomization of patients was done before informed
consent was obtained for participation in an interview
with the interviewer.
Statistical analysis
Analyses will be performed according to the intention to
treat principle, which means that everyone who is rando-
mized stays in the group in which they were randomized.
Statistical package for the social sciences, version 15.0
will be used to analyze the data. The primary outcome
measure is the differences between ACTE and CAU
regarding the number of patients who were out-of-
contact with mental health services. Secondary outcome
measures are improvement of psychosocial functioning
(total HoNOS 65+ score, total score from baseline to the
final interview after 18 months), need-for-care over time
(primary outcome measures), the number of crisis con-
tacts and (in)voluntary admissions, and the number of
admission days (these last 3 measures will be retrieved
from administration files) The interviewer collects the
other secondary outcome measures (subjective quality of
life and client satisfaction.) Categorical variables shall be
analyzed using chi-square tests. Mixed models with
repeated measurement were applied for the continuous
outcomes. This model will be used because of the ability
to include participants with missing data. Missing data at
the second and third interview will be imputed with the
last carried out interview.
Ethical considerations
Because the patients included in the study are difficult
to engage, they will be allocated randomly over the two
conditions without asking informed consent. This Zelen
design [24] and the execution of this study were
approved by the Dutch union of medical-ethic trial
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committees for mental health organizations. Data will be
processed anonymously. Confidential information and
patient names will be treated according to the medical
confidentiality rules. All personal details will be awarded
a code to which only the research team has the key.
Research procedures & timelines
This study will proceed in four stages:
a. Preparation for data collection (1 March 2008 to
1 July 2008)
b. Inclusion of patients (1 July 2008 to 1 August
2010)
c. Follow-up (1 April 2009 to 1 March 2012)
d. Data-analysis, publication of articles, knowledge
transfer, and writing of a thesis (1 March 2012 to
1 March 2013).
Discussion
The central research question in this study is whether
ACTE can ensure that elderly people with SMI remain
in care and whether ACTE can reduce psychosocial
symptoms and unmet needs more than CAU. Other
research questions include whether the intervention can
reduce the number of crisis contacts, reduce the number
and duration of voluntary and involuntary admissions,
and improve quality of life and client satisfaction.
This study will thus provide opportunities to examine
how well ACTE works in practice with this group of
elderly people, and whether it has any extra value over
CAU. By helping to increase overall understanding of var-
ious forms of mental healthcare, its implementation may
lead to an evidence-based intervention for this special
group. If ACTE is shown to have added value, it can be
implemented, and further research can follow.
The study results will be prepared for national and
international publication and for presentation at national
and international conferences. They may also lead to the
publication of a handbook on ACT for the elderly.
This study has two specific strengths and two limita-
tions. The first strength is that we will use and RCT
design to test the effectiveness of ACT for the elderly.
The second is its internal validity, which is protected by
the structured protocol monitoring the ACT model, as
well assessing the contents of the CAU by also applying
the DACTS scale.
The first limitation is the fact that community mental
healthcare professionals and the independent research
assessor will not be blinded for which patients are
included in this study. Because the only way in which
independent research assessor can reach elderly people
with SMI is through collaboration with the community
mental healthcare professionals, it will not be possible to
blind them both. The second limitation is that CAU
exists of different kind of teams in different area, with
different working methods. These working methods will
be describe in the outcome of the DACTS but can nega-
tively or positively affect the outcome results. In addition,
the effects of ACTE will also depend on the CAU. When
the quality of care of the CAU is high, there is less
chance of demonstrating an effect of ACTE. This limita-
tion is a problem in all studies comparing a new inter-
vention with CAU [49]. Therefore, we will describe CAU
thoroughly also using the DACTS, to demonstrate in
what aspects ACTE and CAU differ.
The last limitation is the inclusion format. We started
with the following inclusion criteria: (1) age 65 year or
Table 2 Overview of outcome measurements
Variable Instrument Assessed by Baseline 9
month
18
month
Socio-demographics Patient records Interviewer X X X
Psychiatric history Patient records Psychiatrist or
doctor
X
Psychiatric DSM IV Patient Psychiatrist or X X X
diagnosis records doctor
Drop-out Registration system Researcher X X X
Crisis contacts Registration system Researcher X X X
Admission days Registration system Researcher X X X
Psychosocial functioning HoNOS 65+ Interviewer X X X
Care need CANE short version Interviewer X X X
Quality of life QoL Interviewer X X X
Satisfaction with care One question on 7- point Likert scale Interviewer X X X
Collaboration between patient and care-
provider
Working Relationship Questionnaire for Case
Management
Care provider X X X
ACT model fidelity DACTS Trained ACT
evaluators
X X
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older; (2) having a severe mental illness, (3) no motiva-
tion for treatment, and (4) having four or more addi-
tional problems within the following domains: addiction,
somatic problems, activities of daily living, housing, day-
time activities, social relationships, finances, or police
contacts. Untill June 2009 only 35 patients were
included. Therefore we broadened our inclusion criteria
by lowering the minimum age to 60 years. January 2010
only 50 patients were enrolled and we decided to limit
the number of problems in several domains to 2 (was
4). Finally, in March 2010 we included only 56 patients,
and then we let loose of criterion no 4. At the end of
the trial by July 31 2010 we recruited 64 participants.
Till August 1st 2010, fife patients died, 3 in the interven-
tion group and 2 in the control group (no suicides).
Because of the number of patients enrolled in this study
(64 patients) the power of the study is a problem.
List of abbreviation used
ACT: Assertive Community Treatment; ACTE: Assertive Community Treatment
for the elderly; CANE: Camberwell Assessment of Needs Elderly; CAU: Care as
Usual; DACTS: Dartmouth Assertive Community Treatment Scale; HoNOS:
Health Of the Nation Outcome Scale; QoL: Quality of Life; RCT: Randomized
Controlled Trial; SMI: Severe Mental illnesses.
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